Pathani Ayurvedの総収入は2023-24年度で23.15%上昇し,営業収益が低下したにもかかわらず. Patanjali Ayurved's total income rose 23.15% in 2023-24 despite a drop in operational revenue.
インドの保健・FMCG企業であるパタジャリ・アーユルヴェッドは,パタジャリ・フードスのIPOと他の企業からの収入により,2023-24年に総収入が23.15%増加し,9,335.32億円となった. Patanjali Ayurved, an Indian health and FMCG company, saw its total income rise by 23.15% to ₹9,335.32 crore in 2023-24, due to the IPO of Patanjali Foods and income from other entities. しかし,食品事業の移転により,営業収入は14.25%減って6,460.03億円となった. However, revenue from operations fell by 14.25% to ₹6,460.03 crore due to the transfer of its food business. にもかかわらず,同社は,総利益の5倍もの増額を,UHW2,901.10の小売店に報告した. Despite this, the company reported a five-fold increase in total profit to ₹2,901.10 crore.